HCA Healthcare Inc (NYSE:HCA) – Equities research analysts at SunTrust Banks reduced their Q2 2020 earnings estimates for HCA Healthcare in a research note issued to investors on Monday, July 6th. SunTrust Banks analyst D. Macdonald now expects that the company will post earnings of ($0.24) per share for the quarter, down from their prior forecast of $0.34. SunTrust Banks currently has a “Buy” rating and a $140.00 target price on the stock. SunTrust Banks also issued estimates for HCA Healthcare’s Q3 2020 earnings at $1.93 EPS and Q4 2020 earnings at $3.54 EPS.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, April 21st. The company reported $2.33 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $2.64 by ($0.31). HCA Healthcare had a negative return on equity of 304.76% and a net margin of 5.90%. The firm had revenue of $12.86 billion during the quarter, compared to the consensus estimate of $13.12 billion. During the same period in the previous year, the firm earned $2.97 EPS. The business’s revenue was up 2.7% compared to the same quarter last year.

A number of other analysts also recently issued reports on the company. TheStreet downgraded HCA Healthcare from a “b-” rating to a “c+” rating in a research note on Monday, March 30th. Raymond James reduced their price objective on HCA Healthcare from $165.00 to $130.00 and set an “outperform” rating on the stock in a research note on Monday, April 20th. Oppenheimer reduced their price objective on HCA Healthcare from $160.00 to $135.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 22nd. Credit Suisse Group reissued a “buy” rating and set a $173.00 target price on shares of HCA Healthcare in a research report on Thursday, March 19th. Finally, Deutsche Bank cut their target price on HCA Healthcare from $165.00 to $132.00 and set a “buy” rating on the stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a sell rating, one has issued a hold rating and fifteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $147.81.

NYSE:HCA opened at $94.34 on Thursday. HCA Healthcare has a 1 year low of $58.38 and a 1 year high of $151.97. The stock’s 50 day simple moving average is $102.83 and its two-hundred day simple moving average is $118.13. The company has a market cap of $32.29 billion, a price-to-earnings ratio of 10.73, a PEG ratio of 2.12 and a beta of 1.30.

In other HCA Healthcare news, insider Jon M. Foster sold 24,220 shares of the company’s stock in a transaction on Wednesday, May 6th. The stock was sold at an average price of $100.19, for a total value of $2,426,601.80. Following the transaction, the insider now owns 49,212 shares of the company’s stock, valued at approximately $4,930,550.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 1.80% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of HCA. Envestnet Asset Management Inc. grew its position in shares of HCA Healthcare by 19.0% during the 4th quarter. Envestnet Asset Management Inc. now owns 43,887 shares of the company’s stock worth $6,487,000 after buying an additional 7,006 shares in the last quarter. Raymond James Financial Services Advisors Inc. grew its position in shares of HCA Healthcare by 7.4% during the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 52,272 shares of the company’s stock worth $7,727,000 after buying an additional 3,604 shares in the last quarter. ProShare Advisors LLC grew its position in shares of HCA Healthcare by 17.1% during the 4th quarter. ProShare Advisors LLC now owns 60,248 shares of the company’s stock worth $8,905,000 after buying an additional 8,797 shares in the last quarter. Franklin Resources Inc. grew its position in shares of HCA Healthcare by 14.6% during the 4th quarter. Franklin Resources Inc. now owns 216,941 shares of the company’s stock worth $32,066,000 after buying an additional 27,630 shares in the last quarter. Finally, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in shares of HCA Healthcare by 2.4% during the 4th quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 64,339 shares of the company’s stock worth $9,510,000 after buying an additional 1,513 shares in the last quarter. 68.71% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Strike Price

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.